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Abstract 
Objectives: To determine stability of acetylsalicylic acid (ASA) and sodium salicylate (SS) stock solutions, 
and to determine plasma concentrations of SS in swine after administration in drinking water. 
Materials and methods: Stock solutions of liquid ASA and SS products were placed in a nursery 
environment for 24 hours (Trial One). Salicylate concentrations were measured at 0, 8, 16, and 24 hours 
using high pressure liquid chromatography (HPLC). In Trial Two, SS was metered into the drinking water 
of four groups of pigs in a commercial nursery, at stock solution concentrations of 2268 mg per L (T1), 
4913 mg per L (T2), 9827 mg per L (T3), and 19,654 mg per L (T4). Controls received nonmedicated 
water. Plasma salicylate concentrations in 10 pigs per group were measured at 0, 24, 60, and 72 hours. 
Results: Salicylate concentration ranges of stock solutions in Trial One were 4.04 to 4.61 g per L (ASA) 
and 8.19 to 9.34 g per L (SS). In Trial Two, mean plasma salicylate concentration ranges for treated 
groups over the 72-hour study were 0.17 to 0.41 mg per L (T1), 0.03 to 1.28 mg per L (T2), 0.44 to 1.41 mg 
per L (T3), and 0.62 to 7.22 mg per L (T4). Mean concentrations increased at 24 hours post study 
initiation, then decreased for all treated groups at 60 hours. 
Implications: Solubilities of ASA and SS products differ. Sodium salicylate administered via a water-
medication system reaches measurable plasma concentrations in nursery pigs. Consistency of dosing 
may be variable. 
Keywords 
swine, pharmacology, anti-inflammatory drugs, aspirin 
Disciplines 
Large or Food Animal and Equine Medicine | Veterinary Pathology and Pathobiology | Veterinary 
Toxicology and Pharmacology 
Comments 
This article is published as Patterson, Abby R., Locke A. Karriker, Michael D. Apley, and Paula M. Imerman. 
"Plasma concentrations of sodium salicylate in nursery pigs treated orally." Journal of Swine Health and 
Production 15, no. 3 (2007): 146-151. Posted with permission. 
This article is available at Iowa State University Digital Repository: https://lib.dr.iastate.edu/vdpam_pubs/150 
Journal of Swine Health and Production	—	May	and	June	2007146
Original research Peer reviewed
Plasma	concentrations	of	sodium	salicylate	in	nursery	pigs	
treated	orally
Abby R. Patterson; Locke A. Karriker, DVM, MS, Diplomate ACVPM; Michael D. Apley, DVM, PhD, Diplomate ACVCP; Paula M. 
Imerman, MS, PhD
Summary
Objectives: To determine stability of ace-
tylsalicylic acid (ASA) and sodium salicy-
late (SS) stock solutions, and to determine 
plasma concentrations of SS in swine after 
administration in drinking water.
Materials and methods: Stock solutions of 
liquid ASA and SS products were placed in 
a nursery environment for 24 hours (Trial 
One). Salicylate concentrations were mea-
sured at 0, 8, 16, and 24 hours using high 
pressure liquid chromatography (HPLC). 
In Trial Two, SS was metered into the 
drinking water of four groups of pigs in a 
commercial nursery, at stock solution con-
centrations of 2268 mg per L (T1), 4913 
mg per L (T2), 9827 mg per L (T3), and 
19,654 mg per L (T4). Controls received 
nonmedicated water. Plasma salicylate 
concentrations in 10 pigs per group were 
measured at 0, 24, 60, and 72 hours.
Results: Salicylate concentration ranges 
of stock solutions in Trial One were 4.04 
to 4.61 g per L (ASA) and 8.19 to 9.34 
g per L (SS). In Trial Two, mean plasma 
salicylate concentration ranges for treated 
groups over the 72-hour study were 0.17 to 
0.41 mg per L (T1), 0.03 to 1.28 mg per 
L (T2), 0.44 to 1.41 mg per L (T3), and 
0.62 to 7.22 mg per L (T4). Mean concen-
trations increased at 24 hours post study 
initiation, then decreased for all treated 
groups at 60 hours.
Implications: Solubilities of ASA and SS 
products differ. Sodium salicylate admin-
istered via a water-medication system 
reaches measurable plasma concentrations 
in nursery pigs. Consistency of dosing may 
be variable.
Keywords: swine, pharmacology, anti-
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Resumen - Concentraciones en plasma 
de salicilato de sodio en cerdos del 
destete tratados oralmente
Objetivos: Determinar la estabilidad de 
soluciones madres de ácido acetilsalicílico 
(ASA por sus siglas en inglés) y salicilato de 
sodio (SS por sus siglas en ingles), y deter-
minar las concentraciones en plasma de SS 
en cerdos después de la administración en 
el agua de bebida.
Materiales y métodos: Las soluciones 
madres SS y ASA líquidos se colocaron en 
un medioambiente de destete por 24 horas 
(Prueba Uno). Las concentraciones de salici-
lato se midieron a las 0, 8, 16, y 24 horas uti-
lizando cromatografía líquida de alta presión 
(HPLC por sus siglas en inglés). En la Prueba 
Dos, el SS se midió en el agua de bebida 
de cuatro grupos de cerdos de un destete 
comercial, en concentraciones de soluciones 
madre de 2268 mg por L (T1), 4913 mg por 
L (T2), 9827 mg por L (T3), y 19,654 mg 
por L (T4). Los controles recibieron agua no 
medicada.  Se midieron las concentraciones 
en plasma de salicilato en 10 cerdos por 
grupo a las 0, 24, 60, y 72 horas.
Resultados: Los rangos de concentración 
del salicilato de las soluciones madre en la 
Prueba Uno fueron de 4.04 a 4.61 g por 
L (ASA) y 8.19 a 9.34 g por L (SS). En la 
Prueba Dos, los rangos de concentración 
promedio del salicilato en plasma para 
los grupos tratados durante el estudio de 
72 horas fueron de 0.17 a 0.41 mg por 
L (T1), 0.03 a 1.28 mg por L (T2), 0.44 
a 1.41 mg por L (T3), y 0.62 a 7.22 mg 
por L (T4). Las concentraciones promedio 
incrementaron a las 24 horas después del 
inicio del estudio, y luego disminuyeron a 
las 60 horas en todos los grupos tratados.
Implicaciones: La solubilidad de los pro-
ductos de ASA y SS difiere. El salicilato de 
sodio administrado a través de un sistema 
de medicación por agua alcanza concen-
traciones medibles en plasma en cerdos de 
destete. La consistencia de la dosis puede 
ser variable.
 
Résumé - Concentrations plasmatiques 
de salicylate de sodium chez des porce-
lets en pouponnière traités oralement
Objectifs: Déterminer la stabilité de solu-
tions mères d’acide acétylsalicylique (ASA) 
et de salicylate de sodium (SS), et mesurer 
les concentrations plasmatiques de SS chez 
des porcs suite à l’administration dans l’eau 
de boisson.
Matériels et méthodes: Des solutions 
mères d’ASA et de SS ont été mises dans 
l’environnement d’une pouponnière pour 
une durée de 24 heures (Expérience 1). Les 
concentrations de salicylate ont été mesurées 
par chromatographie liquide à haute pres-
sion (HPLC) après 0, 8, 16, et 24 heures. 
Lors de l’Expérience 2, le SS a été administré 
dans l’eau de boisson à quatre groupes de 
porcs dans une pouponnière commerciale 
à des concentrations de 2268 mg par L 
(T1), 4913 mg par L (T2), 9827 mg par L 
(T3) et 19,654 mg par L (T4). Les animaux 
témoins ont reçu de l’eau non-médicamen-
tée. Les concentrations de salicylate plas-
matique chez 10 porcs par groupe ont été 
mesurées à 0, 24, 60, et 72 heures.
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Acetylsalicylic acid (aspirin; ASA) is commonly used as an analgesic, antipyretic, and anti-inflammatory 
drug1 in animals, although the Food and 
Drug Administration Center for Veterinary 
Medicine has never approved ASA for these 
purposes.2 Aspirin and sodium salicylate 
(SS) appear to be widely used in food-
animal production due to the inexpensive 
cost, over-the-counter availability,3 and the 
lack of anti-viral drugs approved for use 
in food animals (Dr Mike Apley, personal 
communication, 2004). Additionally, 
clinical outbreaks of viral diseases, such 
as porcine reproductive and respiratory 
syndrome and swine influenza, have not 
been adequately controlled with current 
vaccination protocols (ie, outbreaks are still 
common). Consequently, producers com-
monly use ASA or SS products to offset the 
performance losses associated with pyrexia 
and anorexia. The reported effectiveness of 
using aspirin in this manner is varied and 
based on anecdotal information.
The major mechanism by which aspirin 
exerts both its beneficial and negative effects 
is inhibition of prostaglandin synthesis.4-6 
Aspirin irreversibly inhibits both cyclooxy-
genase-1(COX-1) and COX-2 by acetylat-
ing a serine at the active site. Although 
inhibition of COX by ASA has been well 
elucidated, salicylate (the metabolic deriva-
tive of ASA) shows no practical anti-COX 
activity, although it still has anti-inflamma-
tory actions.4 While the exact mechanism of 
action for SS’s anti-inflammatory effects has 
not been determined, multiple theories have 
emerged. Amman and Peskar (2002) 7 have 
reviewed possible mechanisms.
Very little reported information exists 
on the dosage or plasma concentrations 
achieved in swine following administration 
of ASA or SS via a water medication sys-
tem. For pain in swine, the USP Veterinary 
Pharmaceutical Information Monographs2 
recommends an oral dose of 10 mg per kg 
of ASA per 6 to 8 hours (30 to 40 mg per 
kg per day). It is suggested that this dose be 
increased to 2 mg per kg per hour (48 mg 
per kg per day) if a “water supply” is used 
for administration. The corresponding 
water dose for SS would be 1.8 mg per kg 
per hour or 43 mg per kg per day. How-
ever, the type of water medication system 
the ASA dosage applies to is not specified, 
nor are references cited concerning the 
assumptions made in calculation of this 
dosage (eg, water consumption per hour, 
equal opportunity to drink). Other refer-
ences list similar recommendations.1,5,8 No 
recommendations of dosages for antipyretic 
or anti-inflammatory purposes were found. 
In humans, the target serum or plasma 
concentration for analgesia is the same as 
for antipyresis (20 to 50 mg per L), while 
targets for anti-inflammatory purposes are 
generally higher (eg, for treatment of rheu-
matoid arthritis, target serum concentra-
tion is approximately 200 mg per L).9
In 1972, Davis and Westfall10 published 
pharmacokinetic parameters of SS in pigs. 
In that study, gelatin capsules of SS were 
administered orally at three dose levels to 
swine (n = 4), and the resulting plasma 
concentrations were reported. Sodium 
salicylate was also administered intra-
venously (IV) and the resulting plasma 
concentrations, half life, and volume of 
distribution were reported.10 While Davis 
and Westfall’s study provided important 
IV pharmacokinetic parameters, plasma 
concentrations of salicylate after adminis-
tration of ASA or SS through swine water 
systems have not been reported.
Due to the widespread use of ASA and SS 
products despite the lack of oral dosage 
information, there is potential for harm 
to treated animals. Products are currently 
marketed in various forms, including pow-
ders and liquids. Only liquid products were 
investigated in this study due to product 
availability and widespread use, and to 
eliminate potential variability associated 
with mixing a dry product. Thus, the aims 
of this study were to investigate the stabil-
ity of stock solutions of ASA and SS, and 
to determine plasma concentrations in 




Study design: All ASA products used in 
this study claimed to have a concentration 
of 120 mg active ingredient per mL, and 
all SS products, a concentration of 485.6 
mg active ingredient per mL. A representa-
tive liquid SS product (Liquid Asp-Rin; 
AgriLabs, St Joseph, Missouri) and a rep-
resentative liquid ASA product (Asp-Rin 
Concentrate; AgriLabs) were selected for 
the study. A stock solution of each selected 
product was prepared, placed in a commer-
cial nursery environment for 24 hours, and 
sampled at 0, 8, 16, and 24 hours. After 
initial preparation, stock solutions were not 
remixed during the 24-hour trial. Concen-
trations of ASA and SS in these samples 
were quantified against a standard curve 
using a previously described analytical high 
pressure liquid chromatography (HPLC) 
 procedure.11
Preparation of stock solutions: The stock 
solution for each product was prepared 
assuming a target dose of 10 mg of active 
ingredient per kg body weight, average 
water consumption of 11% of body weight 
per day, body weight of 18 kg, and medica-
tion rate of 1 part stock solution to 128 
parts drinking water. Specifically, 88.9 mL 
of the SS product was added to 3.8 L of 
water and 354.9 mL of the ASA product 
was added to 3.8 L of water to achieve a 
stock solution concentration of 11.2 g per 
L for each product. As prepared, the SS 
stock solution concentration was approxi-
mately 37% of the labeled stock solution 
concentration (8 oz per gallon of SS 
product per gallon, or approximately 240 
mL per 3.8 L). As prepared, the ASA stock 
solution concentration was approximately 
12 times the labeled stock solution concen-
tration (1 oz  per gallon of ASA product, or 
30 mL per 3.8 L).
Trial	Two
Study animals and housing. Mixed-breed 
9-week-old pigs of commercial genotypes, 
weighing 18.19 ± 2.75 kg (mean ± SD), 
were used in this trial. Pigs were housed in 
the commercial nursery used in Trial One. 
The building was ventilated by negative 
pressure and contained 40 central pens 
plus raised pens along the outside walls. 
Pens were separated by two walkways, had 
Résultats: Les plages de concentration 
de salicylate des solutions stocks dans 
l’Expérience 1 étaient de 4.04 à 4.61 g par 
L (ASA) et de 8.19 à 9.34 par L (SS). Dans 
l’Expérience 2, les plages de la concentration 
plasmatique moyenne de salicylate pendant 
la période de 72 heures de l’étude étaient de 
0.17 à 0.41 mg par L (T1), 0.03 à 1.28 mg 
par L (T2), 0.44 à 1.41 mg par L (T3), et 
0.62 à 7.22 mg par L (T4). Les concentra-
tions moyennes augmentaient 24 heures 
après le début de l’expérience, puis diminu-
aient à 60 heures pour tous les groupes traités.
Implications: La solubilité de l’ASA et du 
SS diffère. Le salicylate de sodium admin-
istré à l’aide d’un système permettant la 
médication par l’eau atteint des concentra-
tions plasmatiques mesurables chez des 
porcelets en pouponnière. L’uniformité du 
dosage peut être variable.
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slatted floors, and contained an average 
of 4.3 m2 floor space per pen. Each pen 
contained four nipple waters and a six-hole 
stainless steel self feeder, and housed an 
average of 16.4 pigs (range, 11 to 19 pigs 
per pen). The room was segregated by gen-
der, and only animals in the gilt half of the 
room were used in the study.
Biosecurity on this site was good (eg, gated 
entrance, shower facilities, locked exterior 
doors, current visitor log). No clinical signs 
were present in the animals at the time 
of the study. Historical data on previous 
diseases in the herd were unknown. Animal 
care in this study was approved by the 
Committee on Animal Care at Iowa State 
 University.
Selection of treatment product. It was 
assumed that an 18-kg pig consumes water 
at the rate of 11% of its body weight per 
day. If the ASA product is metered into the 
drinking water at a rate 1:128 and ASA has 
a water solubility of 3.33 g per L,12 then 
the highest achievable dose of ASA would 
be 2.98 mg per kg. The water solubility of 
SS is 1111.1 g per L.12 Under the given 
assumptions, the highest achievable dose 
of SS would be 994.1 mg per kg. There-
fore, as a higher dose could potentially be 
achieved, the SS product was selected for 
use in Trial Two.
Treatment groups. Fifteen pens were 
divided into five groups (three pens per 
treatment group) so that each treatment 
group received a different dose of the SS 
product (Liquid Asp-Rin) or no treatment 
(negative controls). Stock solutions for 
the five treatment groups were calculated 
to achieve the following daily doses of SS 
(based on body weight): 2.22 mg per kg 
(T1); 4.45 mg per kg (T2); 8.89 mg per 
kg (T3); and 17.78 mg per kg (T4). The 
control group (T5) received nonmedicated 
 water.
Stock solution preparation. Concentra-
tions of stock solutions were calculated 
assuming an SS product with an active 
ingredient concentration of 485.6 mg per 
mL, and medication rate of 1 part stock 
solution to 128 parts drinking water. Stock 
solutions were prepared every 24 hours 
for each of the four treated groups. The 
following stock solution SS concentrations 
were prepared: 2268 mg per L (T1); 4913 
mg per L (T2); 9827 mg per L (T3); and 
19,654 mg per L (T4).
Modifications to water delivery system. 
Treatment and control pens from which 
animals were sampled (one pen per group 
of three pens) were plumbed individu-
ally with new 1/2-inch internal diameter 
PVC pipe, 5/8-inch garden hose, 1/2-inch 
nipple waterers, and 1/2-inch galvanized 
pipes from the nipples to the fresh water 
source. Pens were medicated in groups of 
three to ensure a sufficient flow of water 
through the medicator; thus, one water 
medicator (HN55 Chemilizer Medicator; 
Chemilizer, Largo, Florida) and one water 
meter (1-inch C-700 Kent Water Meter; 
Elster AMCO Water, Ocala, Florida) were 
installed per treatment group. The control 
pens were plumbed with a water meter 
 only.
Study design. Before the trial began, a 
sample was collected from the main water 
supply to the nursery room and tested for 
coliforms, nitrates-nitrites, and sulfates by a 
certified water-testing facility and for cop-
per and iron by the Iowa State University 
Veterinary Diagnostic Laboratory (Ames, 
Iowa). The pH of the sample was measured 
with a digital pH meter (PHB-320; Omega 
Engineering, Stamford, Connecticut). 
Drinking water for groups T1, T2, T3, 
and T4 was medicated continuously for 
72 hours using stock solutions prepared 
daily. Samples for assay of salicylate were 
collected from each stock solution at 0, 
24, and 48 hours after preparation. Water 
volume (in gallons) and specific time of 
the reading were recorded twice daily 
throughout the trial for each of the five 
water meters. One pen per treatment group 
was selected for collection of water samples 
from the water nipples at 0, 24, and 48 
hours to assay for salicylate (ie, five of the 
15 pens were sampled). Water was allowed 
to flow for 1 minute from two water 
nipples per pen, then a 9-mL sterile blood 
vial was filled from each nipple.
Prior to initiation of treatment, a conve-
nience sample of 10 pigs was selected from 
each of the five sampled pens. Selected 
pigs were ear-tagged and blood samples 
were collected for determination of plasma 
salicylate concentration before initiation 
of treatment (time 0) and 24, 60, and 72 
hours later. At 72 hours, blood samples 
were collected from all pigs in the trial for 
determination of hematocrit, and all pigs 
were then weighed on a digital scale (Salter 
Electro Samson Hanging Scale; Salter 
Brecknell Weighing Products, Fairmont, 
 Minnesota).
Assays for salicylate. Water samples were 
tested for salicylate as described for Trial 
One. Plasma samples were extracted for 
salicylate according to the sample prepara-
tion procedure of Abu-Qare and Abou-
Doniz13 and quantified against a matrix 
curve of 100, 500, 1000, and 5000 ppb 
using the analytical HPLC procedure of 
McMahon and Kelly.11
Statistical analysis. Descriptive statistics 
of the plasma concentrations of salicylate 
for each treatment group (including the 
mean, SD, maximum, and minimum) are 
reported. The statistical program JMP Sta-
tistical Discovery 6.0.0 (SAS, Cary, North 
Carolina) was used to calculate variables. 
No statistical comparison of variables was 
performed. No statistical analysis was per-
formed on the data in this trial, as only one 
treatment group for each SS stock solution 




The ASA stock solution crystallized out of 
solution while the SS product did not. The 
SS product retained more active ingredi-
ent in solution than the ASA product 
(Figure 1). Concentrations of the stock 
solutions over the 24-hour study period 
ranged from 4.04 to 4.61 g per L for the 
ASA product and from 8.19 to 9.34 g per 
L for the SS product.
Trial	Two
The coliform bacterial count in the water 
sample collected from the nursery site 
before the study began was < 1 colony 
forming unit (CFU) per 100 mL total 
(maximum contaminant level [MCL] 
allowable by the Environmental Protection 
Agency = 1 per 100 mL). Sulfate concen-
tration was 78 mg per L (MCL = 250 mg 
per L); nitrate-nitrite concentration was 
< 0.5 mg per L (MCL = 10 mg per L); and 
copper and iron levels were < 0.1 mg per L 
and 0.6 mg per L, respectively. The pH of 
the water sample was 6.305.
The concentration of SS in the stock solu-
tions at each time point, determined by 
HPLC analysis, the average concentrations 
over the 72-hour trial, and the calculated 
target concentrations for each treatment 
group are shown in Table 1.
The concentrations of SS in the water nipple 
samples at each time point, determined by 
HPLC analysis, the average concentrations 
over the 72-hour trial, and the calculated 
target concentrations for each treatment 
group are shown in Table 2.
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Discussion
Under conditions in the nursery barn, the 
ASA stock solution, prepared at a concen-
tration of 11.2 g per L, crystallized out of 
solution, while the SS product remained 
in solution. This agrees with published 
solubility data, ie, the solubility of ASA in 
water is 3.33 g per L while the solubility of 
SS in water is 1111.1 g per L.12
Solubility, the amount of a substance that 
will dissolve in a given amount of another 
substance,17 depends on the chemical 
nature of the compound as well as on 
temperature and pressure. In Trial One, 
both compounds were tested under com-
mercial nursery conditions. To simulate 
normal production temperatures, pressures, 
and mixing conditions, solutions were 
not remixed during the 24-hour period. 
At all times, stock solutions contained 
numerically less active ingredient of the 
ASA product than of the SS product. Since 
even a sample taken directly after mixing 
shows that stock solutions contained less of 
the ASA product, it is clear that a medica-
tor would take up more SS product than 
ASA product. Under the conditions of this 
study, the highest achievable dose of ASA 
in swine would be 3.1 mg per kg per day. 
This dose is considerably less then that 
recommended for relief of pain in swine, 
which is 48 mg per kg per day for ASA 
administered in drinking water.2
The results of the water-quality testing 
were acceptable for total coliform bacteria 
and well below the MCLs set by the Envi-
ronmental Protection Agency for sulfate 
and nitrate-nitrite. The pH and copper and 
iron levels were not compared to levels at 
other production systems within the same 
geographic area, but are provided as a refer-
ence to increase the external validity of this 
study. These covariates must be taken into 
account when extrapolating the plasma 
concentration data from this study to other 
production situations.
As water consumption is difficult to mea-
sure accurately under field conditions, the 
second trial could not accurately measure 
individual pig water intake, and hematocrit 
was tested at the 72-hour sampling period 
to ensure that there was no clinically 
important difference in hydration status 
among the groups. The average hematocrit 
for all animals was 0.27 L per L (range 
= 0.22 to 0.32 L per L). The reported 
“normal” range for swine, 0.28 to 0.46 L 
per L,14-16 was compiled from available 
Figure 1: Changes in concentrations of acetylsalicylic acid (ASA) and sodium 
salicylate (SS) in stock solutions exposed to nursery conditions for 24 hours after 
preparation (Trial One). The ASA solution was prepared by adding 354.9 mL of a 
liquid ASA product to 3.8 L of water and the SS solution was prepared by add-
ing 88.9 mL of a liquid SS product to 3.8 L of water to achieve a stock solution 
concentration of 11.2 g per L for each product. Samples collected at 0, 8, 16, 








































0 hours 24 hours 48 hours
T1 2400 1350 2350 2033 2268
T2 5100 4200 4950 4750 4913
T3 10300 7150 10350 9267 9827
T4 18100 13750 17400 16417 19654
T5 0 0 0 0 0
Table 1: Mean concentrations of sodium salicylate in stock solutions used in 
water medicators for nursery pigs (Trial Two)*
*    Drinking water was medicated continuously for 72 hours using stock solutions pre-
pared daily, except in group T5 (negative controls). Treatment groups were housed in 
three pens per group (11 to 19 pigs per pen; approximately 4.4 m2 of floor space per 
pen), with four water nipples per pen and one water medicator serving each group.
†    Salicylate concentration determined by high pressure liquid chromatography.
‡    Average concentration across the 72-hour study.
Plasma salicylate concentrations for all treat-
ment groups during the trial are shown in 
Table 3.
Mean body weights (± SD) for the treat-
ment groups at 72 hours were 18.72 ± 
3.63 kg (T1); 16.98 ± 1.80 kg (T2);  
17.77 ± 1.88 kg (T3); 17.79 ± 3.49 kg 
(T4); and 19.73 ± 2.31 kg (T5). Mean 
hematocrits (± SD) for the treatment 
groups at 72 hours were 0.28 ± 0.027 L 
per L (T1); 0.27 ± 0.025 L per L (T2); 
0.27 ± 0.023 L per L (T3); 0.25 ± 0.026 L 
per L (T4); and 0.28 ± 0.031 L per L (T5). 
Average hematocrits for all pigs was 0.27 L 
per L (reference range for swine,14-16 0.28 
to 0.46 L per L).
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60-hour samples for all groups is unknown. 
Samples collected from the water nipples 
indicated that the amount of SS presented 
to the pigs was variable, especially at the 
24-hour water sample. Daily water-meter 
readings and stock solution disappearance 
confirmed water movement through the 
system at the targeted dosing rate of 1 part 
stock solution to 128 parts water, and no 
leaks were observed. However, if the water 
had been accidentally turned off and back 
on between sampling periods, the pigs 
might have compensated by drinking more 
water, which would result in increased 
plasma concentrations in the 24-hour sam-
ples. The water meter would not show fluc-
tuations in water disappearance, as only the 
total amount of water through the system 
was recorded. Although accidental shut-
off was possible, it was not noted by the 
researchers. Actual stock solution concen-
trations correlated well with the calculated 
target concentration. However, there was 
significant variation in instantaneous con-
centration of salicylate at the water nipple. 
These fluctuations in SS concentration in 
the water at any specific time, coupled with 
variations in the frequency and volume of 
consumption events between pigs, may 
introduce significant variation in individual 
pig dose and subsequent response to treat-
ment. The cyclic, mechanical action of the 
medicator may have been responsible for 
the variation in concentration measured at 
the nipple and the measured discrepancy 
between the actual and calculated water 
concentrations, especially in T3 at the 60-
hour time point. Larger, thoroughly mixed 
samples from water nipples should be col-
lected in future studies. Additional evalu-
ation of the variation of water dosing over 
time is warranted, using a wide spectrum 
of medication devices employed in pig 
barns. The reason for the decrease in serum 
plasma salicylate concentrations for T3 at 
the 60-hour sampling point is unknown 
with any certainty, although it correlates 
with the decrease in concentration of 
salicylate in the water-nipple samples at 
this time  point.
Implications
• Major differences in the solubilities of 
ASA and SS products have an impact 
on product choice, depending on the 
target dose in the pig.
• Sodium salicylate administered orally 
through a water-medication system 
is absorbed and reaches measurable 
plasma concentrations.
Table 2: Mean concentrations of sodium salicylate in samples of drinking 
water from water nipples in a system supplied by water medicators (Trial Two)*
Treatment 
group
Salicylate concentration at 








0 hours 24 hours 48 hours
T1 11.5 11.0 12.0 11.50 17.71
T2 39.0 18.0 15.5 24.17 38.38
T3 76.5 3.5 46.0 42.00 76.77
T4 118.5 4.5 108.5 77.17 153.54
T5 0 0 0 0 0
*    Water system and treatment groups described in Table 1.
†    Salicylate concentrations determined by high pressure liquid chromatography.
‡    Average concentration across the 72-hour study.
Table 3: Mean plasma concentrations of salicylate in groups of nursery pigs 
treated with a liquid sodium salicylate product in the drinking water for 72 
 hours (Trial Two)*
*    Water system and treatment groups described in Table 1. Concentrations of sodium 
salicylate in the stock solutions and in drinking water samples from the water 
nipples are shown in Tables 1 and 2, respectively.
Time 
(hours)
Salicylate concentration ± SD (mg/L)
T 1 (range) T 2 (range) T 3 (range) T 4 (range) T5 (range)
0 0 ± 0  
(0 - 0)
0 ± 0  
(0 - 0)
0 ± 0  
(0 - 0)
0 ± 0  
(0 - 0)
0 ± 0  
(0 - 0)
24 0.41 ± 0.31 
(0.1 - 1.1)
1.28 ± 1.03  
(0.1 - 3.2)
1.41 ± 0.64  
(0.6 - 2.3)
7.22 ± 2.31  
(4.2 - 11.1)
0 ± 0   
(0 - 0)
60 0.17 ± 0.15 
(0 - 0.4)
0.82 ± 0.77 
(0 - 2.5)
0.44 ± 0.50 
(0 - 1.5)
2.66 ± 2.41 
(0 - 5.2)
0 ± 0  
(0 - 0)
72 0.27 ± 0.20 
(0.2 - 0.8)
0.03 ± 0.07 
(0 - 0.2)
1.24 ± 0.79 
(0.2 - 2.7)
0.62 ± 0.48) 
(0.1 - 1.4)
0 ± 0  
(0 - 0)
information, including laboratory animal 
recommendations,14 miniature swine 
data,15 and slaughter-line blood collection 
data.16 Readers should note that hema-
tocrit reference ranges for swine are not 
commonly used. The available references 
were included to provide a comparison for 
this study, even though the reference popu-
lations varied from the population in this 
trial. In future studies, hematocrit could 
be tested at each data collection point, or 
water disappearance could be monitored 
throughout the trial to assess the effect 
decreased water consumption might have 
on plasma salicylate concentrations.
Plots of plasma concentrations over time 
after water administration of known quan-
tities of SS are needed to determine the 
bioavailability of the drug. Bioavailability 
is calculated by comparing the area under 
the plasma concentration curve (AUC) to 
the AUC determined after IV administra-
tion in the same study population. The 
sampling intervals in this study were not 
sufficient to determine an accurate AUC, 
and an IV comparison study was not con-
ducted. The data presented in this study 
will provide a reference for achievable 
plasma concentrations after administration 
of an SS product via a water medication 
 system.
The data presented in this study confirm 
that nursery pigs absorb SS administered 
in the drinking water. The reason for the 
decrease in plasma concentrations in the 
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• The consistency of SS dosing using in-
line water medicators may be highly 
 variable.
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